About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Thy1-APP)3Somm
transgene insertion 3, Bernd Sommer
MGI:2447146
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Tg(Prnp-ITM2B*)6Jckr/0
Tg(Thy1-APP)3Somm/0
B6.Cg-Tg(Prnp-ITM2B*)6Jckr Tg(Thy1-APP)3Somm MGI:4452490
cx2
Lamp5em1Lmit/Lamp5em1Lmit
Tg(Thy1-APP)3Somm/0
involves: C57BL/6 * C57BL/6J * DBA/2 MGI:7608060
cx3
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Thy1-APP)3Somm/0
involves: C57BL/6 * C57BL/6J * DBA/2 MGI:4833965
cx4
Lamp5em1Lmit/Lamp5+
Tg(Thy1-APP)3Somm/0
involves: C57BL/6 * C57BL/6J * DBA/2 MGI:7608059
cx5
Abca1tm1Jdm/Abca1tm1Jdm
Tg(Thy1-APP)3Somm/0
involves: C57BL/6J * DBA/1LacJ * DBA/2 MGI:4833954
tg6
Tg(Thy1-APP)3Somm/0 B6.Cg-Tg(Thy1-APP)3Somm MGI:3720731
tg7
Tg(Thy1-APP)3Somm/0 involves: C57BL/6 * C57BL/6J * DBA/2 MGI:7608058
tg8
Tg(Thy1-APP)3Somm/0 involves: C57BL/6J * DBA/2 MGI:2652447


Genotype
MGI:4452490
cx1
Allelic
Composition
Tg(Prnp-ITM2B*)6Jckr/0
Tg(Thy1-APP)3Somm/0
Genetic
Background
B6.Cg-Tg(Prnp-ITM2B*)6Jckr Tg(Thy1-APP)3Somm
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Prnp-ITM2B*)6Jckr mutation (0 available)
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• at 13 months, mice exhibit a 70% reduction in neocortical amyloid beta deposition compared with Tg(Thy1-APP)3Somm mice

homeostasis/metabolism
• mice exhibit an accumulation of Dan-amyloid in separate plaques from amyloid beta plaques
• at 13 months, mice exhibit a 70% reduction in neocortical amyloid beta deposition compared with Tg(Thy1-APP)3Somm mice




Genotype
MGI:7608060
cx2
Allelic
Composition
Lamp5em1Lmit/Lamp5em1Lmit
Tg(Thy1-APP)3Somm/0
Genetic
Background
involves: C57BL/6 * C57BL/6J * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lamp5em1Lmit mutation (0 available); any Lamp5 mutation (28 available)
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice exhibit earlier and more rapid mortality and poor overall survival compared to single Tg(Thy1-APP)3Somm hemizygotes

behavior/neurological
• mice show increased hyperactivity over the entire test period compared to single Tg(Thy1-APP)3Somm hemizygotes
• memory could not be tested due to high premature mortality rate

nervous system
• hippocampal EEG recordings show a further increase in spontaneous discharges and spike trains than seen in single Tg(Thy1-APP)3Somm hemizygotes
• spectral power at gamma (30-100 Hz) frequency is increased more than in single Tg(Thy1-APP)3Somm hemizygotes or Lamp5em1Lmit/Lamp5+ Tg(Thy1-APP)3Somm/0 mice, indicating neuronal network hypersynchronicity
• theta/gamma cross frequency coupling, an EEG measure linked to memory, is disrupted more than in single Tg(Thy1-APP)3Somm hemizygotes




Genotype
MGI:4833965
cx3
Allelic
Composition
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Thy1-APP)3Somm/0
Genetic
Background
involves: C57BL/6 * C57BL/6J * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Thy1-APP)3Somm mutation (1 available)
Tnfrsf1atm1Imx mutation (6 available); any Tnfrsf1a mutation (47 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• at 24 months, mice exhibit little neuronal loss unlike Tg(Thy1-APP)3Somm mice
• mice exhibit less microglial activation compared with Tg(Thy1-APP)3Somm mice
• at 24 months, mice exhibit reduced amyloid plaques compared with Tg(Thy1-APP)3Somm mice
• mice exhibit reduced cerebral amyloid angiopathy compared with Tg(Thy1-APP)3Somm mice

behavior/neurological
N
• mice exhibit normal exploratory learning and memory retention unlike Tg(Thy1-APP)3Somm mice

hematopoietic system
• mice exhibit less microglial activation compared with Tg(Thy1-APP)3Somm mice

immune system
• mice exhibit less microglial activation compared with Tg(Thy1-APP)3Somm mice

homeostasis/metabolism
• at 24 months, mice exhibit reduced amyloid plaques compared with Tg(Thy1-APP)3Somm mice
• mice exhibit reduced cerebral amyloid angiopathy compared with Tg(Thy1-APP)3Somm mice




Genotype
MGI:7608059
cx4
Allelic
Composition
Lamp5em1Lmit/Lamp5+
Tg(Thy1-APP)3Somm/0
Genetic
Background
involves: C57BL/6 * C57BL/6J * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lamp5em1Lmit mutation (0 available); any Lamp5 mutation (28 available)
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• survival is reduced similarly to that seen in single Tg(Thy1-APP)3Somm hemizygotes until 150 days and thereafter shows a trend towards increased mortality

behavior/neurological
• learning in the Morris water maze is impaired compared to single Tg(Thy1-APP)3Somm hemizygotes at 12 months of age
• memory formation in the Morris water maze is impaired compared to single Tg(Thy1-APP)3Somm hemizygotes at 12 months of age

homeostasis/metabolism
• amyloid beta formation and plaque load in aged mice is similar to single Tg(Thy1-APP)3Somm hemizygotes

nervous system
• amyloid beta formation and plaque load in aged mice is similar to single Tg(Thy1-APP)3Somm hemizygotes
• spectral power at gamma (30-100 Hz) frequency is increased more than in single Tg(Thy1-APP)3Somm hemizygotes, indicating neuronal network hypersynchronicity
• theta/gamma cross frequency coupling, an EEG measure linked to memory, is disrupted more than in single Tg(Thy1-APP)3Somm hemizygotes




Genotype
MGI:4833954
cx5
Allelic
Composition
Abca1tm1Jdm/Abca1tm1Jdm
Tg(Thy1-APP)3Somm/0
Genetic
Background
involves: C57BL/6J * DBA/1LacJ * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Abca1tm1Jdm mutation (1 available); any Abca1 mutation (88 available)
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• fewer than expected mice are present at weaning

nervous system
• mice exhibit more cerebral amyloid angiopathy-associated cerebral hemorrhage than Tg(Thy1-APP)3Somm mice
• at 13 months, mice exhibit more cerebral amyloid angiopathy than in Tg(Thy1-APP)3Somm mice

cardiovascular system
• mice exhibit more cerebral amyloid angiopathy-associated cerebral hemorrhage than Tg(Thy1-APP)3Somm mice

homeostasis/metabolism
• mice exhibit a 2-fold increase in insoluble beta-amyloid in the brain compared with Tg(Thy1-APP)3Somm mice
• at 13 months, mice exhibit more cerebral amyloid angiopathy than in Tg(Thy1-APP)3Somm mice




Genotype
MGI:3720731
tg6
Allelic
Composition
Tg(Thy1-APP)3Somm/0
Genetic
Background
B6.Cg-Tg(Thy1-APP)3Somm
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• amyloid plaques are associated with alterations in axonal growth and ectopic synaptic differentiation
• vascular amyloid is associated with ectopic entorhinal boutons
• axons that line the periphery of beta-amyloid plaques exhibit swelling unlike in wild-type mice
• entorhinal fibers extend outside the termination zone unlike in wild-type mice
• commissure axons extend into the outer molecular layer unlike in wild-type mice
• amyloid plaques are associated with alterations in axonal growth and ectopic synaptic differentiation
• vascular amyloid is associated with ectopic entorhinal boutons

behavior/neurological
• at 6 months during the first 2 hours
• impaired acquisition in the Morris water maze; the number of quadrant entries and the escape latencies are higher than in controls
• however, mutants are unaffected in open-field, elevated plus-maze, emergence tests, tests measuring motor coordination, during the probe trial and while swimming towards a visible platform
• in an isolation-induced/resident-intruder paradigm, mice exhibit a 4.6- and 59-fold increase in aggression at 6 and 12 months, respectively, compared with wild-type mice
• 67% of animals exhibit myoclonic jumping behavior in home cage
• reduced number of horizontal and vertical movements in the photocell monitor
• at 3 months, mice exhibit lower light ambulation compared with wild-type mice
• at 6 months, mice exhibit increased in the ratio of dark to light ambulation during the second half of the active phase compared with wild-type mice
• at 12 months, circadian locomotor patterns are more constant than in wild-type mice
• at 12 months, mice exhibit increased dark and total ambulation compared with wild-type mice
• at 12 months, dark ambulation level is bimodal unlike in wild-type mice
• overnight at 12 months

growth/size/body
• 29% weight reduction compared to wild-type

homeostasis/metabolism
• amyloid plaques are associated with alterations in axonal growth and ectopic synaptic differentiation
• vascular amyloid is associated with ectopic entorhinal boutons

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:80449




Genotype
MGI:7608058
tg7
Allelic
Composition
Tg(Thy1-APP)3Somm/0
Genetic
Background
involves: C57BL/6 * C57BL/6J * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• male, and more so, female mice show reduced survival

behavior/neurological
• 2-month-old mice present with slower habituation in the open field test, before development of memory deficits
• 2-month-old mice present with in the open field test, before development of memory deficits

homeostasis/metabolism
• amyloid beta formation and plaque

nervous system
• amyloid beta formation and plaque
• hippocampal EEG recordings show increased spontaneous discharges and spike trains compared to controls
• spectral power analysis shows increased high frequency power compared to controls

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:345459




Genotype
MGI:2652447
tg8
Allelic
Composition
Tg(Thy1-APP)3Somm/0
Genetic
Background
involves: C57BL/6J * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Thy1-APP)3Somm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• mice exhibit aneurysm-like vasodilation unlike in wild-type mice
• mice exhibit blood vessel ruptures that range from microhemorrhages to large hematomas unlike wild-type mice
• mice exhibit leakage in the blood-brain barrier unlike wild-type mice
• develop amyloid beta deposits in the neocortex and hippocampus starting at 6 months of age, which increase in size and number with age (J:44603)
• by 24 months of age, deposits occupy a substantial area of the neocortex and hippocampus and are found in the thalamus and olfactory nucleus and are isolated in the caudate putamen (J:44603)
• develop almost exclusively congophilic plaques already at their first appearance (J:44603)
• at 24 months (J:134832)
• in the neocortex, hippocampus, and thalamus and to a lesser degree in other regions such as septum, striatum, brainstem, and white matter (J:67583)
• mutants exhibit inflammatory responses in the brain, showing a massive glial response
• loss of pyramidal neurons in the vicinity of amyloid beta deposits in the CA3 area
• local distortion of the cholinergic fiber network is seen in the vicinity of plaques
• local loss of neurons in the vicinity of plaques
• at 24 months

immune system
• mutants exhibit inflammatory responses in the brain, showing a massive glial response

cardiovascular system
• mice exhibit aneurysm-like vasodilation unlike in wild-type mice
• mice exhibit smooth muscle cell degeneration in amyloid laden blood vessels unlike wild-type mice
• bicuculline-treated mice exhibit delayed and reduced amplitude of changes in cerebral blood volume compared with similarly treated wild-type mice
• at 25 months, acetazolamide-treated mice exhibit a smaller increase in the percent change of cerebral blood volume compared with similarly treated wild-type mice
• mice exhibit blood vessel ruptures that range from microhemorrhages to large hematomas unlike wild-type mice
• mice exhibit leakage in the blood-brain barrier unlike wild-type mice
• mice exhibit cerebral amyloid angiopathy associated vasculitis unlike wild-type mice

muscle
• mice exhibit smooth muscle cell degeneration in amyloid laden blood vessels unlike wild-type mice

homeostasis/metabolism
• develop amyloid beta deposits in the neocortex and hippocampus starting at 6 months of age, which increase in size and number with age (J:44603)
• by 24 months of age, deposits occupy a substantial area of the neocortex and hippocampus and are found in the thalamus and olfactory nucleus and are isolated in the caudate putamen (J:44603)
• develop almost exclusively congophilic plaques already at their first appearance (J:44603)
• at 24 months (J:134832)
• in the neocortex, hippocampus, and thalamus and to a lesser degree in other regions such as septum, striatum, brainstem, and white matter (J:67583)
• bicuculline-treated mice exhibit delayed and reduced amplitude of changes in cerebral blood volume compared with similarly treated wild-type mice
• at 25 months, acetazolamide-treated mice exhibit a smaller increase in the percent change of cerebral blood volume compared with similarly treated wild-type mice
• during posthypoxic recovery, the spike amplitude in hippocampal region CA1 after stimulation of Schaffer collaterals in region CA3 is less than in similarly treated wild-type mice
• at 4 months, hypoxic tolerance is impaired compared to in similarly treated wild-type mice

behavior/neurological
• at 6 months, mice exhibit reduced exploratory learning compared with wild-type mice
• object recognition is impaired compared to in wild-type mice

hematopoietic system

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:44603
cerebral amyloid angiopathy DOID:9246 J:67583





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory